本研究探討廠商技術來源對創新績效之影響，主要朝兩方面研究，第一、公司組織疆界內外的技術探索是如何影響組織之創新績效，第二、公司專門技術領域內外的探索如何影響組織之創新績效。在研究方法，是以全球前四大製藥公司為樣本，運用專利搜尋收集資料，然後利用相關性及追蹤資料(Panel data)的模式分析，對於公司組織及專門技術領域內外與領域內外衝擊變數進行實證研究。本研究重要結論，第一、應專注在自己公司內部的專門技術領域創新。主要觀察到公司傾向於以本身知識及技術建構能力去發展技術創新; 而專門技術領域外的技術創新，須要增加外部知識獲取及相關技術支援。第二、廠商是屬於高度研發密集產業，能夠持續專精在自己公司特有製藥領域內專長研究，因此，在公司組織內領域內能夠提供更有效的技術領域內創新。第三、在非製藥領域的研究，須要有公司組織外領域外專長研究支援，故在公司組織外領域外能夠提供更有效的專門技術領域外創新。

This research focuses on the impact of company’s technological resources, and the effect on a company’s innovation. There are two objectives of this research. One is to understand how technological research and development within a company and within an industry affects the performance of a company’s innovation. The second objective is to understand how research and development within and outside a company’s specialty affects the performance of the company’s innovation. The study was done by collecting patent data from the top four pharmaceutical companies in the world, and analyzing their patent data by correlation and panel data analyses. There are three major conclusions that can be drawn from this research. First, a company should focus on technological innovation within a company’s specialty. This conclusion is based on the observation that a company tends to focus on knowledge collection within their main technologies. However, technological innovation outside a company’s expertise requires external support of knowledge collection and related technologies. The second conclusion of this research is that if companies belonging to an industry with a high density of research and development continue to focus their research and development on their expertise, the technological innovation within those companies can be more efficient. The third conclusion of this research is that in non-drug manufacture’s research, companies need external support from different companies and different fields of technology; thus, technological innovation outside of a non-drug manufacture’s research can be more efficient.

一、英文部份
1.Ahuja, G. and Katila, R.（1999）, ‘Searching distant domains: How geography and science search promote innovation. ’, Working paper, University of Texas at Austin.
2.Ahuja, G.（2000）, ‘Collaboration networks, structural holes, and innovation： a longitudinal study. ’, Administrative Science Quarterly, 45, pp. 425-455.
3.Ahuja, G. and Katila, R.（2001）, ‘Technological acquisitions and the innovation performance of acquiring firms： a longitudinal study. ’, Strategic Management Journal, 22（3）, pp. 197-220.
4.Albert, M., Avery, D., Narin, F. and Mcallister, P.（1991）, ‘Direct validation of citation counts as indicators of industrially important patents. ’, Research Policy, 20（3）, pp. 251-259.
5.Almedia, P.（1996）, ‘Knowledge sourcing by foreign multinationals： patent citation analysis in the U.S. semiconductor industry. ’, Strategic Management Journal, Winter Special Issue, 17, pp. 155-165.
6.Ansoff, H. I and McDonnell, E. J.（1990）, ‘Implanting Strategic Management.’, 2nd ed., N.J.： Prentice-Hall.
7.Arora, A., and Gambardella, A.（1994）, ‘Evaluating technological information and utilizing it： scientific knowledge, technological capability, and external linkages in biotechnology.’, Journal of Economic Behavior & Organization, 24（1）, pp. 91-114.
8.Arundel, A., and Kabla, I.（1998）, ‘What percentage of innovations are patented? Empirical estimates for European firms.’ , Research Policy, 27（2）, pp. 127-141.
9.Auster, E.（1990）, ‘The inter-organizational environment: network theory, tools and applications.’ , In Technology Transfer: A Communications Perspective, Williams F, Gibson D (eds.), Sage: Newbury Park, CA., pp. 63-89.
10.Barney, J. B.（2002）, ‘Gaining and Sustainin Competitive Advantage.’, 2nd ed., N.J.： Prentice-Hall.
11.Barney, J.B.（1991）, ‘Firm resources and sustained competitive advantage. ’, Journal of Management, 17, pp. 99-120.
12.Bierly, P. and Chakrabarti, A.（1996）, ‘Generic knowledge strategies in the U.S. pharmaceutical industry. ’, Strategic Management Journal, 17（winter special issue）, pp. 123-135.
13.Blundell, R., Griffith, R. and Van Reenen, J （1995）, ‘Dynamiccount data models of technological innovation. ’, Economic Journal, 105（429）, pp. 333-344.
14.Cardinal, L. B. and Hatfield, D. E.（2000）, ‘Internal knowledge generation： the research laboratory and innovative productivity in the pharmaceutical industry. ’, Journal of Engineering and Technology Management, 17, pp. 247-271.
15.Charlene, L.N. and Carolyn Y, W. (2003), ‘Technology sourcing and output of established firms in a regime of encompassing technological change. ’, Strategic Management Journal, 24, pp.651-666.
16.Chen, C. J. and Lin, B.W.（2004）, ‘The effects of environment, knowledge attribute, organizational climate, and firm characteristics on knowledge sourcing decisions. ’, R&D Management, 34, pp.137-146.
17.Clarke, J. and Turner, P.（2004）, ‘Global competition and Australian biotechnology industry： Developing a model of SMEs Knowledge management strategies.’ , Knowledge and Process Management, 11（1）, pp. 38-46.
18.Cockburn, I, Henderson, R.M. and Stern, S.（2000）, ‘Untangling the origns of competitive advantage. ’, Strategic Management Journal, Special Issue, 21（10-11）, pp.1123-1145.
19.Coff, R. W.（2003）, ‘The emergent knowledge-based theory of competitive advantage： An evolutionary approach to Integrating economics and management.’ , Managerial and Decision Economic, 24, pp. 245-251.
20.Cohen, W. M. and Levinthal, D.A.（1989）, ‘Innovation and learning： the two faces of R&D. ’, Economic Journal, 99（397）, pp.569-596.
21.Cohen, W. M. and Levinthal, D.A.（1990）, ‘Absorptive capacity： a new perspective on learning and innovation. ’, Administrative Science Quarterly, 34, pp.128-152.
22.Comanor, W.S. and Scherer, F.M.（1969）, ‘Patent statistics as a measure of technical change. ’, Journal of Political Economy, 77（3）, pp.392-398.
23.Comanor, W.（September 1986）, ‘The political economy of the pharmaceutical industry.’, Journal of Economic Literature, pp. 1178-1217.
24.Cool, K., Roller, L.H. and Leleux, B.（1999）, ‘The relative impact of actual and potential rivalry on firm profitability in the paharmaceutical industry. ’, Strategic Management Journal, 20（1）, pp.1-14.
25.Cummings, J. N.（2004）, ‘Work Groups, Structural Diversity, and Knowledge Sharing in a Global Organization.’ , Management Science, 50（3）, pp. 352-364.
26.Davis, S., and Botkin, J.（1994）, ‘The coming of knowledge-based business.’ , Harvard Business Review, September-October, pp. 165-170.
27.Dutta, S. and Weiss, A.M.（1997）, ‘The relationship between a firm’s level of technological innovativeness and its pattern of partnership agreements. ’, Management Science, 43（3）, pp. 343-356.
28.Dyer, J. and Singh, H.（1998）, ‘The relationship view: cooperative strategy and sources of interorganizational competitive advantage. ’, Academy of Management Review, 23, pp. 660-679.
29.Engelsman, E.C. and van Raan, A.F.J.（1994）, ‘A patent-based cartography of technology. ’, Research Policy, 23, pp. 1-26.
30.Ernst, H.（2001）, ‘Patent applications and subsequent changes of performance： evidence from time-series cross-section analyses on the firm level. ’, Research Policy, 30（1）, pp. 143-157.
31.Fleming, L.（2001）, ‘Recombinant uncertainty in technological search. ’, Management Science (forthcoming).
32.Fleming, L. and Sorenson, O.（2001）, ‘Technology as a complex adaptive system： Evidence from patent data. ’, Research Policy, 30（7）, pp. 1019-1039.
33.Fleming, L. and Sorenson, O.（2004）, ‘Science as a map in technological search. ’, Strategic Management Journal, Special issue 25（8-9）, pp. 909-928.
34.Galunic, D.C. and Rodan, S.（1998）, ‘Resource recombinations in the firm： Knowledge structures and the potential for schumpeterian innovation. ’Strategic Management Journal, 19（12）, pp. 1193-1201.
35.Gambardella, A.（1995）, ‘Science and innovation in the US pharmaceutical industrial.’, Cambridge University Press, Cambridge.
36.Grant, R. M.（1996）, ‘Toward a knowledge-based theory of the firm.’, Strategic Management Journal, 17, pp. 109-122.
37.Graves, S. B. and Langowitz, N.S.（1993）, ‘Innovative productivity and returns to scale in the pharmaceutical industry.’, Strategic Management Journal, 14（8）, pp. 593-605.
38.Griliches, Z.（1984）, ‘Introduction. In R&D, patents and Productivity.’ , Griliches Z (ed). University of Chicago Press: Chicago, IL, pp. 1-20.
39.Griliches, Z.（1990）, ‘Patent statistics as economic indicators： a survey.’, Joural of Economic Literature, 28, pp. 1661-1707.
40.Hair, J.F., Anderson, R.E., Tatham, R.L. and Black, W.C.(1995)‘Multivariate data analysis with readings.’, New York: Macmillan.
41.Hagedoorn, J and Schakenraad, J. (1994) , ‘The effect of strategic technology alliances on company performance.’, Strategic Management Journal, 15（4）, pp. 291-309.
42.Hall, B.H., Griliches, Z. and Hausman, J（1986）, ‘Patent and R and D： is there a lag?.’, International Economic Review, 27（2）, pp. 265-283.
43.Hall, B.H., Jaffe, A. and Trajtenberg, M.（2000）‘Market value and patent citations： a first look.’ , NBER working paper no. 7741.’（available http：//www.nber.org/patents/）
44.Hall, B.H., Jaffe, A.B. and Trajtenberg, M.（2001）, ‘The NBER Patent Citation Data File： Lessions, insights and methodological tools.’ , NBER working paper no. 8498.’（available http：//www.nber.org/patents/）
45.Harhoff, D., Narin, F., Scherer, F.M. and Vopel, K（1999）, ‘Citation frequency and the value of patented inventions.’, Review of Economics and Statistics, 81, pp. 511-515.
46.Hariolf, G. and Ulrich, S. (1999), ‘Patent statistics in the age of globalisation: New legal procedures, new analytical methods, new economic interpretation. ’, Research Policy, 28(4), pp.377-397.
47.Heiman, B. A. and Nickerson, J. A. （2004）, ‘Empirical evidence regarding the tension between knowledge sharing and knowledge expropriation in collaborations. ’, Managerial and Decision Economic, 25, pp.401-420.
48.Helfat, C. E.（1994a）, ‘Evolutionary trajectories in petroleum firm R&D. ’, Management Science, 40（12）, pp.1720-1747.
49.Helfat, C. E.（1994b）, ‘Firm-specificity in corporate applied R&D. ’, Organization Science, 5（2）, pp.173-184.
50.Helfat, C. E.（1997）, ‘Know-how and asset complementarity and dynamic capability accumulation： the case of R&D. ’, Strategic Management Journal, 18（5）, pp.339-360.
51.Henderson, R. M. and Clark, K. B.（1990）, ‘Architectural innovation： the recongfiguration of existing product technologies and the failure of established firms. ’, Administrative Science Quarterly, 35, pp.9-30.
52.Henderson, R. M. and Cockburn, I.（1994）, ‘Measuring competence? Exploring firm effects in pharmaceutical research. ’, Strategic Management Journal, Winter Special Issue 15, pp.63-84.
53.Henderson, R. M. and Cockburn, I.（1996）, ‘Scale, scope, and spillovers: the determinants of research productivity in drug discovery. ’, RAND Journal of Economics, 27(1), pp.32-59.
54.Hill, C.W.L. and Rothaermel, F.T.（2003）‘The performance of incumbent firms in the face of radical technological innovation.’, Academy of Management Review, 28, pp. 257-274.
55.Hitt, M. A., Johnson, R. A. and Moesel D. D.（1996）, ‘The market for corporate control and firm innovation.’, Academy of management Journal, 35（9）, pp. 1084-1119.
56.Hsiao, C. (1986), ‘Analysis of Panel Data. ’, Cambridge University Press, Cambridge, New York.
57.Jaffe, A.（December 1986）, ‘Technological opportunities and spillovers of R&D. ’, American Economics Review, pp.984-1001.
58.Jaffe, A. B., Fogarty, M. and Banks, B.（1998）, ‘Evidence from patents and patent citations on the impact of NASA and other federal labs on commercial innovation. ’, Journal of Industrial Economics, 46, pp.183-205.
59.Jaffe, A. B., Trajtenberg, M. and Henderson, R.（1993）, ‘Geographic localization of knowledge spillovers as evidenced by patent citations. ’, Quarterly Journal of Economics, 108, pp.577-598.
60.Jaffe, A. B., Trajtenberg, M. and Fogarty, M.S（2000）, ‘The meaning of patent citations： report on the NBER/Case-Western Reserve Survey of Patentees. ’, NBER working paper no. 7631.
61.Katila, R.（2002）, ‘New product search over time： past ideas in their prime.’, Academy of Management Journal, 45（5）, pp. 995-1010.
62.Katila, R. and Ahuja, G.（2002）, ‘Something old, something new： a longitudinal study of search behavior and new product introduction. ’, Academy of Management Journal, 45, pp. 1183-1194.
63.Khalil, T.（2000）, ‘Management of Technology. ’, McGraw-Hill.
64.King, A.A. and Tucci, C.L.（2002）, ‘Incumbent entry into new market niches： the role of experience and managerial choice in the creation of dynamic capabilities. ’, Management Science, 48（2）, pp. 171-186.
65.Kogut, B. and Zander, U.（1992）, ‘Knowledge of the firm, combinative capabilities, and the replication of technology. ’, Organization Science, 3(3), pp. 383-397.
66.Lane, P.J., and Lubatkin, M.（1998）, ‘Relative absorptive capacity and interorganizational learning. ’, Strategic Management Journal, 19（5）, pp. 461-477.
67.Lanjouw, J.O., Pakes, A. and Putnam, J.（1998）, ‘How to count patents and value intellectual property： the uses of patent renewal and application data’, Journal of Industrial Economics, 46（4）, pp. 405.
68.Lawless, M.W. and Anderson P.（1996）, ‘Generational technological change： effects of innovation and local rivalry on performance.’, Academy of Management Journal, 39（5）, pp.1185-1217.
69.Leonard-Barton, D.（1992）, ‘Core capabilities and core rigidities: a paradox in managing new product development.’ , Strategic Management Journal, Summer Special Issue, 13, pp. 111-126.
70.Leonard-Barton, D.（1995）, ‘Wellsprings of Knowledge: Building and Sustaining the Sources of innovation.’ , Harvard Business School Press: Boston, MA.
71.Lerner, J.（1995）, ‘Patenting in the shadow of competitors.’ , Journal of Law and Economics, 38, pp.463-495.
72.Levin, R.C.（1986）,‘A new look at the patent system.’, American Economic Review, 76（2）, pp. 200.
73.Levin, R.C., Klevorick, A.K., Nelson, R.R., Winter, S.G., Gilbert, R. and Griliches, Z.（1987）, ‘Appropriating the returns from industrial research and development: comments and discussion.’, Brookings Papers on Economic Activity, 3 , pp. 783-831.
74.Levinthal, D.A. and March J.G.（1993）,‘The myopia of learning.’, Strategic Management Journal, Winter Special Issue 14, pp. 95-112.
75.Linder, J. C., Jarvenpaa, S. and Davenport, T. H.（2003）, ‘Toward an Innovation sourcing strategy. ’, MIT Sloan Management Review, 44（3）, pp. 43-49.
76.Loasby, B. J.（1998）, ‘The organization of capabilities. ’, Journal of Economic Behavior and Organization, 35, pp. 139-160.
77.Lubatkin, M. (1983) , ‘Mergers and the performance of the acquiring firm. ’, Academy of Management Review, 8(2), pp. 218-225.
78.Madhavan, R. and Grover, R.（1998）, ‘From embedded knowledge to embodied knowledge： new product development as knowledge management. ’, Journal of Marketing, 62, pp. 1-12.
79.Mansfield, E.（1988）, ‘The speed and cost of industrial innovation in Japan and the United States； External vs. internal technology. ’, Management Science, 34（10）, pp. 1157-1168.
80.March, J.G.（1991）,‘Exploration and exploitation in organizational learning. ’, Organization Science, 2, pp. 71-87.
81.March, J.G. and Simon, H.（1958）, ‘Organizations. ’, Wiley: New York.
82.Markides, C. and Williamson, P.J.（1994）, ‘Related diversification, core competencies, and corporate performance. ’, Strategic Management Journal, Summer Special Issue 15, pp. 149-165.
83.Martin, X. and Mitchell, W.（1998）, ‘The influence of local search and performance heuristics on new design introduction in a new product market. ’, Research Policy, 26（7/8）, pp. 753-771.
84.McAdam, R.（2000）, ‘Knowledge management as a catalyst for innovation within organizations： A qualitative study. ’, Knowledge and Process Management, 7（4）, pp. 233-241.
85.McEvily, S. K. and Chakravarthy, B.（2002）, ‘The persistence of knowledge-based advantage： An empirical test for product performance and technological knowledge.’, Strategic Management Journal , 23（4）, pp. 285-305.
86.McGuire, J. L.（2001）,‘Pharmaceuticals：Classes, Therapeutic Agents, Areas of Application.’, Wiley-VCH
87.McGrath, R. G. and Nerkar, A.（2004）, ‘Real options reasoning and a new look at the R&D investment strategies of pharmaceutical firms.’, Strategic Management Journal, 25（1）, pp. 1-21.
88.McKelvey, M.（1997）, ‘Co-evolution in commercial genetic engineering.’, Industrialand Corporate Change, 6 , pp. 503-532.
89.McKelvey, M. and Orsenigo, L.（2004）, ‘Pharmaceuticals as a sectoral innovation system. In: Malerba, F. (Ed.), Sectoral System of innovation. ’, Cambridge University Press, Cambridge.
90.Miller, D.J.（2004）, ‘Firms’ technological resources and the performance effects of diversification： a longitudinal study.’, Strategic Management Journal, 25（11）, pp. 1097-1119.
91.Morton, F. M. S.（1999）, ‘Entry decisions in the generic pharmaceutical industry. ’, RAND Journal of Economics, 30, pp.421-440.
92.Mowery, D., Oxley, J. and Silverman, B. (1996) , ‘Strategic alliances and interfirm knowledge transfer. ’, Strategic Management Journal, Winter Special Issue, 17, pp.77-92.
93.Nagarajan, A. and Mitchell, W. (1998), ‘Evolutionary diffusion: internal and external methods used to acquire technological changes in the lithotripsy industry. ’, Strategic Management Journal, 19（11）, pp.1063-1077.
94.Narin, F., Carpenter, M.P., and Woolf, P.（1984）, ‘Technological performance assessments based on patents and patent citations. ’, IEEE transactions on Engineering Management, 31（4）, pp.172-183.
95.Nelson, R.R. and Winter, S.G. (1982), ‘An Evolutionary Theory of Economic Change. ’, Belknap Harvard: Cambridge, MA.
96.Nerkar, A.（2003）, ‘Old is gold? The value of temporal exploration in the creation of new knowledge. ’, Management Science, 49（2）, pp.211-229.
97.Nerkar, A. and Roberts, P.W.（2004）, ‘Technological and product-market experience and the success of new product introductions in the pharmaceutical industry. ’, Strategic Management Journal, 25（8/9）, pp.779-799.
98.Nicholls-Nixon, C. L. and Woo, C.Y.（2003）, ‘Technology sourcing and output of established firms in a regime of encompassing technological change. ’, Strategic Management Journal, 24（7）, pp.651-666.
99.Nightingale, P.（2000）, ‘Economies of scale in experimentation: knowledge and technology in pharmaceutical R&D. ’, Industrial and Coporate Change, 9 , pp.315-359.
100.Nonaka, I.（1991）, ‘The knowledge-creating company. ’, Harvard Business Review, 69（6）, pp. 96-104.
101.Palmberg, C.（2004）, ‘The sources of innovations – Looking beyond technological opportunities. ’, Econ. Innov. New Techn., 13（2）, pp. 183-197.
102.Pakes, A. and Griliches, Z. (1984) , ‘Patents and R&D at the firm level: a first look, In R&D, Patents and Productivity. ’, Griliches Z (ed). University of Chicago Press: Chicago, IL.
103.Patel, P. and Pavitt, K.（1994）, ‘The continuing, widespread (and neglected) importance of improvements in mechanical technologies . ’, Research Policy, 23, pp. 533-546.
104.Patel, P. and Pavitt, K.（1997）, ‘The technological competenies of the world’s largest firms： complex and pathdependent, but not much varity. ’, Research Policy, 26, pp. 141-156.
105.Penner-Hahn, J.D.（1998）, ‘Firm and environmental influences on the mode and sequence of foreign research and development activities. ’, Strategic Management Journal, 19（2）, pp. 149-168.
106.Penner-Hahn, J. and Shaver, J.M.（2005）, ‘Does international research and development increase patent output? An analysis of Japanese pharmaceutical firms. ’, Strategic Management Journal, 26（2）, pp. 121-140.
107.Pisano, G.p. (1990) , ‘The R&D performance boundaries of the firm: an empirical analysis. ’, Administrative Science Quarterly, 35, pp. 153-176.
108.Pisano, G.p. (2002) , ‘Pharmaceutical biotechnology. In: Nelson, R.R., Victor, D.G., Steil, B. (Eds.), Technological innovation and Economic performance. ’, Princeton University Press, Princeton, pp. 346-366.
109.Powell, W.（1998）, ‘Learning from collaboration： knowledge and networks in the biotechnology and pharmaceutical industries. ’, California Management Review, 40, pp. 228-240.
110.Prahalad, C.K. and Hamel, G.（1990）, ‘The core competence of the organization. ’, Harvard Business Review , 68（3）, pp. 79-91.
111.Probst, G., Raub, S. and Romhardt, K.（2000）, ‘Managing Knowledge. ’, John Wiley & Sons Inc.
112.Ramani, S.V.（2002）,‘Who is interested in biotech? R&D strategies, knowledge base and market sales of Indian biopharmaceutical firms. ’, Research Policy, 31, pp. 381-398.
113.Roberts, P. W.（1999）, ‘Product innovation, product-market competition and persistent profitability in the U.S. pharmaceutical industry. ’, Strategic Management Journal, 20（7）, pp. 655-670.
114.Roijakkers, N., Hagedoorn, J. and Van Kranenburg, H.（2005）, ‘Dual market structures and the likelihood of repeated ties- evidence from pharmaceutical biotechnology. ’, Research Policy, 34（2）, pp. 235-245.
115.Rosenkopf, L. and Nerkar, A.（1999）, ‘On the complexity of technological evolution: exploring coevolution within and across hierarchical levels in optical disc technology. ’, In variations in Organization Science: In Honor of D.T. Campbell, Baum J, McKelvey W (eds). Stage: Thousand Oaks, CA; pp. 169-183.
116.Rosenkopf, L. and Nerkar, A.（2001）, ‘Beyond local search： boundary spanning, exploration, and impact in the optical disc industry. ’, Strategic Management Journal, 22（4）, pp. 287-306.
117.Rothaermel, F. and Deeds, D.L.（2004）, ‘Exploration and exploitation alliances in biotechnology： a system of new product development. ’, Strategic Management Journal, 25, pp. 201-221.
118.Santors, F. M.（2003）, ‘The co-evolution of firms and their knowledge environment: insights from the pharmaceutical industrial. ’, Technological Forecasting and Social Change, 70, pp.687-715.
119.Scott-Morton, F. M.（2000）, ‘Barries to entry, brand advertising, and generic entry in the U.S. pharmaceutical industry. ’, International Journal of Industrial Organization, 18, pp. 1085-1104.
120.Shane, S. (2001) , ‘Technological opportunities and new firm creation. ’, Management Science, 47, pp. 205-220.
121.Singh, H. and Montgomery, C.A. (1987) , ‘Corporate acquisition strategies and economic performance. ’, Strategic Management Journal, 8(4), pp. 377-386.
122.Silverman, B. S.（1999）, ‘Technological resources and the direction of corporate diversification： toward an integration of the resource-based view and transaction cost economics. ’, Management Science, 45（8）, pp. 1109-1124.
123.Song, M., Droge, C., Hanvanich, S. and Calantone, R.（2005）, ‘Marketing and Technology resource complementarity： an analysis of their interaction effect in two environmental contexts. ’, Strategic Management Journal, 26（3）, pp. 259-276.
124.Sorensen, J.B. and Stuart, T.E. (2000), ‘Aging, obsolescence and organizational innovation. ’, Administrative Science Quarterly, 45, pp. 81-112.
125.Sorenson, O. (2000), ‘Letting the market work for you: An evolutionary perspective on product strategy. ’, Strategic Management Journal, 21, pp. 577-592.
126.Stuart, T.E. and Podolny, J.M.（1996）,‘Local search and the evolution of technological capabilities. ’, Strategic Management Journal, Summer Special Issue 17, pp. 21-38.
127.Teece, D.J., Pisano, G. and Shuen, A.（1997）, ‘Dynamic capabilities and strategic management. ’, Strategic Management Journal, 18（7）, pp. 509-533.
128.Teece, D.J., Pisano, G.P.（1995）, ‘Dynamic capabilities of firms： an introduction. ’, Industrial and Corporate Change, 3, pp. 537-556.
129.Temin, P.（1979）, ‘Technology, regulation, and market structure in the modern pharmaceutical industry. ’, Bell Journal of Economics, 10, pp. 427-446.
130.Thomke, S. and Kuemmerle, W.（2002）, ‘Asset accumulation, interdependence and technological change：evidence from pharmaceutical drug discovery. ’, Strategic Management Journal, 23（7）, pp. 619-635.
131.Trajtenberg, M.（1990）, ‘A penny for your quotes： patent citations and the value of innovations. ’, Rand Journal of Economics, 21（1）, pp. 172-188.
132.Vermeulen, F. and Barkema, H.（2001）, ‘Learning through acquisitions. ’, Academy of Management Journal, 44, pp. 457-476.
133.Wernerfelt, B.（1984）, ‘A resource-based view of the firm. ’, Strategic Management Journal, 5（2）, pp. 171-180.
134.Winter, S.（1987）, ‘Knowledge and competence as strategic assets. ’, In The Competitive Challenge: Strategies for Innovation and Renewal, Teece DJ (ed.). Ballinger: Cambridge, MA, pp. 186-219.
135.Yeoh, P. and Roth, K.（1999）, ‘An empirical analysis of sustained advantage in the U.S. pharmaceutical industry： impact of firm resources and capabilities. ’, Strategic Management Journal, 20（7）, pp. 637-653.
136.Zucker, L.G., Darby, M.R. and Armstrong, J.S.（2002）,‘Commercializing knowledge： university science, knowledge capture, and firm performance in biotechnology. ’, Management Science , 48（1）, pp. 138-153.
137.http://www.contractpharma.com
138.http://www.gsk.com
139.http://www.imshealth.com
140.http://www.jnj.com
141.http://www.learningtech.com.tw
142.http://www.pfizer.com
143.http://www.sanofi-aventis.com
144.http://www.yahoo.com
二、中文部份
1.朱兆文（2000），全球主要藥廠經營策略研究，經濟部技術處，財團法人生物技術開發中心 。
2.秦慶瑤（2004），藥品委外研發及生產的發展現況及趨勢，經濟部技術處，財團法人生物技術開發中心 。
3.陳麗敏、羅淑慧（2004），生技製藥公司的策略聯盟佈局，經濟部技術處，財團法人生物技術開發中心 。
4.經濟部工業局（2005），生技產業白皮書。